Blume Capital Management’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
N
Blume Capital Management's EXEL Position: Q2 2024 in Review
Blume Capital Management sold out of Exelixis (EXEL) in Q2 2024, closing a stake of 400 shares — an estimated $9.49K sold.
Blume Capital Management first reported a position in EXEL in Q4 2018 and held it in 22 quarters. The position peaked at $152K in Q4 2018. 413 funds tracked by Wall St. Rank hold EXEL as of Q2 2024.
- Blume Capital Management reported no remaining Exelixis position as of Q2 2024 after selling out during the quarter.
- Blume Capital Management sold 400 Exelixis shares in Q2 2024, an estimated $9.49K.
- Blume Capital Management first reported a position in Exelixis in Q4 2018 and held it in 22 quarters.
- Blume Capital Management's Exelixis position peaked at $152K in Q4 2018.
- 413 funds tracked by Wall St. Rank held Exelixis as of Q2 2024.
Based on Blume Capital Management's 13F filing for Q2 2024, filed 5 Aug 2024.